Literature DB >> 6178541

Beta-2-microglobulin-specific autoantibodies cause platelet aggregation and interfere with ADP-induced aggregation.

A Falus, K Merétey, D Bagdy, M Diószegi, U Böhm, E Csák, S Bozsóky.   

Abstract

The anti-platelet activity of beta-2-microglobulin (beta 2m) specific autoantibodies isolated from sera of patients with autoimmune diseases was tested in direct and ADP-induced aggregation assays. It was established that human anti-beta 2m autoantibodies and heterologous rabbit anti-beta 2m antibodies evoke a dose-dependent aggregation of human platelets. Anti-beta 2m autoantibodies also impaired ADP-induced platelet aggregation. Antibodies with anti-beta 2m activity could be desorbed from the platelets and lymphocytes of a patients with systemic lupus erythematosus who was not thrombocytopenic. The possibility that such autoantibodies may alter platelet function is considered.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6178541      PMCID: PMC1536362     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

Review 1.  Platelet antibody in autoimmune thrombocytopenia.

Authors:  R H Dixon; W F Rosse
Journal:  Br J Haematol       Date:  1975-10       Impact factor: 6.998

2.  Platelet indirect radioactive Coombs test. Its utilization for PLA1 grouping.

Authors:  J P Soulier; C Patereau; J Drouet
Journal:  Vox Sang       Date:  1975       Impact factor: 2.144

3.  Demonstration of specific T-lymphocyte membrane antigens associated with antibodies inhibiting the mixed leukocyte culture in man.

Authors:  P Wernet; H G Kunkel
Journal:  Transplant Proc       Date:  1973-12       Impact factor: 1.066

4.  The effect of platelet membrane antibodies on aggregation and release.

Authors:  K L Kaplan; R L Nachman
Journal:  Br J Haematol       Date:  1974-12       Impact factor: 6.998

5.  Platelet transfusion therapy; the selection of compatible platelet donors for refractory patients by lymphocyte HL-A typing.

Authors:  R A Yankee; F C Grumet; G N Rogentine
Journal:  N Engl J Med       Date:  1969-11-27       Impact factor: 91.245

6.  Platelet counts with the Coulter counter.

Authors:  B S Bull; M A Schneiderman; G Brecher
Journal:  Am J Clin Pathol       Date:  1965-12       Impact factor: 2.493

7.  Effect of anticoagulant and ABO incompatibility on recovery of transfused human platelets.

Authors:  R H Aster
Journal:  Blood       Date:  1965-12       Impact factor: 22.113

8.  Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura. Physiologic, serologic and isotopic studies.

Authors:  N R Shulman; V J Marder; R S Weinrach
Journal:  Ann N Y Acad Sci       Date:  1965-06-30       Impact factor: 5.691

9.  The effect of HLA antibodies on platelet aggregation.

Authors:  G Holmlund; A Tiilikainen; K Penttinen
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

10.  Recovery of native conformation of rabbit immunoglobulin G upon recombination of separately renatured heavy and light chains at near-neutral pH.

Authors:  I Björk; C Tanford
Journal:  Biochemistry       Date:  1971-04-13       Impact factor: 3.162

View more
  3 in total

Review 1.  Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications.

Authors:  Armen Yuri Gasparyan; Antonios Stavropoulos-Kalinoglou; Dimitri P Mikhailidis; Karen M J Douglas; George D Kitas
Journal:  Rheumatol Int       Date:  2011-02       Impact factor: 2.631

2.  Localization of host immunoglobulin G to the surface of Pneumocystis carinii.

Authors:  W Blumenfeld; R E Mandrell; G A Jarvis; J M Griffiss
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

3.  Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis.

Authors:  Kim L L Habets; Leendert A Trouw; E W Nivine Levarht; Suzanne J A Korporaal; Petra A M Habets; Philip de Groot; Tom W J Huizinga; René E M Toes
Journal:  Arthritis Res Ther       Date:  2015-08-24       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.